Indeed, cellular immunity is known to play a crucial role in SARS-Cov2 infection, as specific CD4 and CD8 responses have been identified in healthy COVID-19-recovered individuals, as well as in recovered agammaglobulinemic patients [53, 54]. The gene discussed is CD8A; the disease is COVID-19.